Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Calcium-binding protein 7 (CABP7) is a member of the calmodulin-related family of small calcium-binding proteins characterized by four EF-hand motifs and a unique C-terminal transmembrane domain. CABP7 and its close homolog CaBP8 form a distinct subfamily (sometimes called calneurons), localizing predominantly to the Golgi and trans-Golgi network via a tail-anchor mechanism rather than N-myristoylation. The primary known function of CABP7 is to negatively regulate Golgi-to-plasma membrane trafficking by directly inhibiting the lipid kinase PI4KIIIβ in a calcium-dependent manner, thereby influencing the production of phosphatidylinositol 4-phosphate (PI4P) and vesicle transport. CABP7 is also implicated in essential cell processes such as cytokinesis. While structurally and functionally related to calmodulin, CABP7 is not known to directly regulate ion channels or serve as a classic drug target at present, and its roles in human disease are still emerging.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calcium-binding protein 7 (CABP7).